| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |